Z Gastroenterol 2022; 60(01): e28
DOI: 10.1055/s-0041-1740740
Abstracts | GASL

Role of endurance training in diet-induced steatohepatitis in rats

Janin Henkel-Oberländer
1   University of Bayreuth; Faculty of Life Science
,
Katja Buchheim-Dieckow
2   University of Potsdam, Institute of Nutritional Sciences
,
JosèP. Castro
3   German Institute of Human Nutrition
,
Thomas Laeger
2   University of Potsdam, Institute of Nutritional Sciences
,
Korinna Jöhrens
4   Carl Gustav Carus University Hospital Dresden
,
GerhardP. Püschel
2   University of Potsdam, Institute of Nutritional Sciences
› Institutsangaben
 

Background Metabolic-associated fatty liver disease (MAFLD) and non-alcoholic steatohepatitis (NASH) are considered hepatic manifestations of metabolic syndrome for which no effective pharmacological treatment exists. Dietary intervention with more than 10% weight loss is effective but often fails due to low patient compliance. Alternatively, an increased physical activity is considered to improve fatty liver disease even without weight loss. The underlying mechanisms are unclear and cannot be studied in humans.

Methods Wistar rats were fed a standard or NASH-inducing high-fat diet with cholesterol and fructose for 7 weeks. Both diet groups were divided into a sedentary and a running exercise group.

Results Animals fed the high-fat diet gained more weight than standard diet-fed animals, got glucose intolerant, and developed a liver pathology with steatosis, inflammation and fibrosis similar to human NASH in the metabolic syndrome. While the endurance training did not reduce body weight or improve the NASH activity score, it significantly reduced the hepatic overload with dietary cholesterol and the resulting oxidative stress. In addition, endurance training improved the diet-induced glucose intolerance, possibly through exercise-induced generation of the hepatokine FGF21, which increased fatty acid utilization in muscle.

Conclusion Endurance training failed to ameliorate diet-induced hepatic fatty liver disease in rats but reduced hepatic cholesterol accumulation and oxidative damage of hepatocytes, as well as high-fat diet-induced glucose intolerance possibly in part by production of the hepatokine FGF21.



Publikationsverlauf

Artikel online veröffentlicht:
26. Januar 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany